Journal Article Summary
The article investigates a new formulation of the antihistamine cetirizine using zinc-layered hydroxide (ZLH) to create a controlled-release nanocomposite. This research is significant because it aims to improve the delivery and effectiveness of cetirizine, which is commonly used to treat allergic reactions. By enhancing the stability and release profile of cetirizine, the study seeks to reduce side effects and improve patient outcomes in managing conditions related to histamine release, such as allergies and asthma.
The researchers synthesized a nanocomposite called CETN by intercalating cetirizine into ZLH and characterized its properties through various techniques. They found that the CETN could release about 96% of cetirizine over 80 hours at a neutral pH, demonstrating a controlled release compared to the rapid release from a physical mixture of cetirizine and ZLH. Additionally, the study showed that CETN was more effective at inhibiting histamine release from basophilic leukemia cells than free cetirizine, indicating that the new formulation might offer enhanced therapeutic benefits.
However, the study has limitations, including its focus on in vitro experiments, which may not fully represent how the formulation behaves in live patients. The cytotoxicity of CETN was also noted, with an IC50 value indicating a concentration at which it could be harmful to cells. Patients should consult healthcare professionals before considering new treatments, especially those involving nanocomposites, to discuss potential risks and benefits based on their individual health needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Hasan Samer, Ali Hussein Al, Al-Qubaisi Mothanna, Hussein Mohd Zobir, Ismail Maznah, Zainal Zulkarnain, Hakim Muhammad Nazrul. Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells. International Journal of Nanomedicine 2012. DOI: 10.2147/IJN.S30809. PMID: 22848164. PMCID: PMC3405893.
Featured Pill Pals Product
Cetirizine 10 mg Tablets - 500 count - Generic For Zyrtec --- DR REDDY
Cetirizine 10 mg Tablets - 500 count - Generic For Zyrtec --- DR REDDY is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
